Cannabis Businesses Intervene in Anti-Rescheduling Lawsuit

Industry Operators Join DEA Defense

Multiple cannabis businesses filed motions to intervene as defendants in the lawsuit challenging DEA's marijuana rescheduling rule. The motions, filed in federal district court, argue that the industry operators have a direct financial stake in the outcome and can't rely on the government alone to represent their interests.

The intervening businesses include multi-state operators and smaller licensed cultivators who stand to benefit from Schedule III classification. Under Schedule III, cannabis businesses would gain access to standard business tax deductions under 26 U.S.C. § 280E, which currently prohibits deductions for businesses trafficking in Schedule I or II substances.

The court hasn't yet ruled on the motions to intervene. Standard procedure allows proposed intervenors to participate in briefing while the court considers their standing.

Original Challenge Targets DEA Authority

The underlying lawsuit, filed by opponents of rescheduling, claims DEA violated the Administrative Procedure Act and exceeded its statutory authority under 21 U.S.C. § 811. Plaintiffs argue the agency failed to follow mandatory procedures for controlled substance scheduling. They also contend DEA ignored evidence that marijuana doesn't meet Schedule III criteria.

The legal challenge centers on whether DEA properly applied the eight-factor analysis required by the Controlled Substances Act when it moved marijuana from Schedule I to Schedule III.

The lawsuit names both DEA and the Department of Justice as defendants. It seeks declaratory and injunctive relief to vacate the rescheduling rule and return marijuana to Schedule I.

DEA finalized the rescheduling rule in May 2026 following a notice-and-comment period that drew over 43,000 public submissions. The rule became effective 60 days after publication in the Federal Register.

Stakes for Cannabis Industry

The outcome will determine whether cannabis businesses retain access to federal tax deductions worth billions of dollars annually. Industry analysts estimate that 280E relief under Schedule III classification would reduce effective tax rates for profitable operators by 30 to 50 percentage points.

State-licensed cannabis programs also have skin in this game. A court order vacating the rescheduling rule would restore the conflict between state legalization frameworks and federal Schedule I status, potentially chilling investment and banking access.

Briefing on the motions to intervene is expected to conclude by late July 2026. For full background on the rescheduling process and litigation, see the CannIntel topic hub on DEA rescheduling.

The district court hasn't yet set a schedule for summary judgment motions or trial. Legal observers expect the case to reach appellate review regardless of the trial court outcome.